Twitter was not quiet as a mouse this week over two animal studies, a survey of cannabis use by autistic people, and a big announcement from the Journal of Neuroscience.

Heating up Twitter feeds this week was a new commentary about a rarely discussed perspective on autism, talk about the use of optogenetics tools to manipulate ‘presynapses,’ a possible explanation for decision-making differences between the sexes, and a striking illustration of the human brain.

The buzz this week hovered around the neurodiversity perspective on autism behavioral interventions, a virtual-reality program designed to help autistic people enter the workforce, and an announcement from an autism journal.

This week’s talk on Twitter included discussion on the merits of impact factors, responses to a Lancet commission’s recommendations for the autism field and research on oxytocin receptors.

This week’s newsletter trails tweets about neuroscientists who study rodents or humans teaming up with those who study nonhuman primates, the expansion of interneurons networks in the human brain and new findings on the autism-linked gene DDX3X.

A trill of tweets this week talk about perspective-taking during conversation, watching hands during playtime and accounting for measurement bias during diagnosis.

Researchers put new findings about COVID-19 and neurodevelopmental conditions in context, tweet about new ways to analyze cortical neuroanatomy and adapt “how it started, how it’s going.”

We’re tracking tweets that highlight, among other things, the futility of ‘data availability statements’ and some possible fixes, plus visions of a peer reviewer dust-up.

On Twitter this week, many researchers toasted the geneticists who won the 2022 Kavli Prize in neuroscience, and others offered helpful reminders for the field.

The autism science community this week tweeted about whether underpowered studies pose ethical questions, if Spectrum 10K should restart and why autistic advocates participate in biomedical research.